| Video
In addition to other shortcomings, current prescribing guidelines are particularly ill-suited to the needs and challenges of patients already on opioid therapy. Drs. Heit and Gourlay discuss the roots of the problem and the role of primary care as talented amateurs in addiction medicine.
| Video
Women with chronic pelvic pain frequently endure long delays in referral to appropriate specialties for diagnosis and care. In this segment, a pain medicine psychologist and a pain medicine specialist outline what primary care should know about the epidemiology, risk factors and etiology of various...
| Video
Opioid induced respiratory depression is associated with over 16,000 deaths in the US each year, and the risks of opioid therapy are not fully understood by many prescribers. Dr. Fudin reviews some of the unanticipated concerns, with a focus on assessing and managing risk for respiratory depression...
| Video
The legal landscape for prescribers of controlled medications for pain and addiction is fraught with risk. Attorney Michael Barnes outlines best practices for prescribing clinicians to protect their patients from harm and themselves from criminal and civil liability.
| Video
In addition to other shortcomings, current prescribing guidelines are particularly ill-suited to the needs and challenges of patients already on opioid therapy. Drs. Heit and Gourlay discuss the roots of the problem and the role of primary care as talented amateurs in addiction medicine.
| Article
A new genetic test has the potential to aid clinicians in identifying patients at risk of addiction to opioids, according to the results of research led by Sherman Chang, PhD, vice president of research and development at AutoGenomics, Inc., Carlsbad, California. The team identified 16 genetic...
| Article
It is possible to provide the best care for a patient and protect yourself from criminal and civil liability. In fact, when you do one right, you do the other right as well. Typically you want to look for three things as a prescriber of any controlled prescription medication, opioid or otherwise...
| Article
Senior PAINWeek faculty member Douglas Gourlay, MD, MSc, FRCPS, FASAM, has spoken often of the need for frontline practitioners with an interest in pain to become “talented amateurs” in addiction medicine. A new consensus document released by the American Society of Addiction Medicine (ASAM) may...
| Video
At PAINWeek 2016, a panel of medical, legal, and pharmacy specialists convened to offer their views on the recently introduced prescribing guidelines for chronic pain from the CDC. In this segment, Dr. Ziegler and Dr. Fudin summarize some of the concerns voiced over the guideline development process...
| Article
Much of the publicity today, as well as initiatives like the CDC guidelines, really focus on the outpatient problems with chronic pain patients. But there’s a growing concern with how we prescribe opioids for post-op pain control. There is a fair amount of literature that’s emerging about whether...